Skip to main content
Clinical Trials/NL-OMON52999
NL-OMON52999
Completed
Not Applicable

Kinetics of immune responses and characteristics of antigen-specific B cells after Bordetella pertussis vaccination - Immune responses to Bordetella pertussis vaccination

eids Universitair Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pertussis
Sponsor
eids Universitair Medisch Centrum
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 30, 2022
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy competent adults, who have received recommended vaccinations according
  • to the vaccination policy in the Netherlands

Exclusion Criteria

  • Subjects who meet any of the following criteria will be excluded from
  • participation in this study:
  • \* has an auto\-immune disease
  • \* has an immune deficiency
  • \* has a bleeding disorder
  • \* underwent splenectomy
  • \* receives immunosuppressive medication
  • \* receives medication which influences blood clotting
  • \* underwent active (clinically manifested) Bordetella pertussis infection at
  • any time point in life or had contact with such a person

Outcomes

Primary Outcomes

Not specified

Similar Trials